Cow's milk protein allergy (CMPA) is one of the most common diagnoses considered when a young baby is unsettled, has skin symptoms, or has gastrointestinal problems. It is also one of the most over-diagnosed conditions in infancy — some estimates suggest that a significant proportion of infants placed on elimination diets do not actually have CMPA. Understanding the clinical features that genuinely suggest CMPA, how it is diagnosed correctly, and what management involves helps parents navigate a confusing area with better information.
Healthbooq supports parents with evidence-based guidance on common infant health concerns, including the specific features of CMPA, how it is distinguished from normal infant unsettledness, and what management involves.
Two Types of Cow's Milk Protein Allergy
CMPA occurs in two immunologically distinct forms that present differently and require different diagnostic approaches.
IgE-mediated CMPA involves the production of IgE antibodies against milk proteins; symptoms occur within minutes to two hours of exposure and can include hives (urticaria), swelling, vomiting, runny nose or sneezing, and in rare cases anaphylaxis. This form is diagnosed by skin prick testing or specific IgE blood testing (RAST) in addition to clinical history, and tends to be more persistent into later childhood.
Non-IgE-mediated CMPA involves a different immune pathway and produces delayed symptoms — typically hours to days after exposure — that are more variable and more difficult to attribute to a specific cause. Symptoms include persistent colic-like crying, reflux symptoms, frequent loose stools or blood in the stools, constipation, eczema that fails to respond to standard treatment, faltering growth, and/or irritability. This is the more common form in young infants and is more frequently misidentified or over-diagnosed because the symptoms overlap significantly with normal infant behaviours.
Diagnosis: The Elimination and Reintroduction Trial
There is no reliable diagnostic test for non-IgE-mediated CMPA: specific IgE testing and skin prick testing are negative in this form, by definition. Diagnosis rests on the clinical history and a supervised elimination and reintroduction trial.
For breastfed infants, this involves the mother eliminating all cow's milk protein from her own diet (including all dairy products, products containing milk ingredients, and sometimes — with clinical guidance — other cross-reactive proteins) for two to four weeks, while monitoring the infant's symptoms. Calcium supplementation for the mother is required during this period. If symptoms improve significantly on elimination, the next step is a supervised reintroduction to confirm the diagnosis — if symptoms return on reintroduction, the diagnosis is confirmed.
For formula-fed infants, the standard formula is replaced with an extensively hydrolysed formula (eHF) or, if necessary, an amino acid-based formula (AAF). NICE guidance recommends eHF as first-line for most infants with suspected CMPA; AAF is used for more severe presentations or when eHF is not tolerated. Partially hydrolysed formulas (comfort formulas) are not recommended for CMPA management.
Management of Confirmed CMPA
For breastfed infants with confirmed CMPA, breastfeeding can continue with the mother maintaining a dairy-free diet. Dietetic support is strongly recommended to ensure nutritional adequacy of the mother's diet.
Most infants with CMPA outgrow the allergy by three to five years. The milk ladder — a structured reintroduction protocol that begins with baked milk (which is less allergenic than fresh milk) and progressively introduces more allergenic forms — is used from around nine to twelve months (under health professional guidance) to assess tolerance and accelerate the development of tolerance where possible.
Over-Diagnosis and Appropriate Use of Elimination Diets
A significant concern in UK paediatric practice is the over-prescription of dairy elimination diets for normal infant unsettledness, reflux, and colic. Healthy infant crying, normal newborn reflux, and colic do not reliably respond to dairy elimination and do not indicate CMPA. The National Institute for Health and Care Excellence (NICE) guidelines on CMPA (NG154) provide a framework for clinical decision-making that aims to prevent unnecessary dietary restriction.
Parents who have concerns about possible CMPA in their infant should discuss these with their GP or health visitor before initiating an elimination diet, as specialist dietetic input is recommended for confirmed cases.
Key Takeaways
Cow's milk protein allergy (CMPA) is the most common food allergy in infancy, affecting approximately 2–3% of UK infants. It presents in two main forms: IgE-mediated (immediate onset, typically within one to two hours of exposure) and non-IgE-mediated (delayed onset, symptoms developing hours to days after exposure). Diagnosis is based on clinical history and a supervised dairy elimination and reintroduction trial. Management involves elimination of cow's milk protein from the infant's diet (or the breastfeeding mother's diet for breastfed infants) and use of an appropriate hypoallergenic formula for formula-fed infants. Most children outgrow CMPA by three to five years.
